![Michel Kaczorek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Michel Kaczorek joined Synt:em SA in 1995 and currently serves as President.
He is a Director of CliniGenetics SA.
Michel Kaczorek active positions
| Companies | Position | Start |
|---|---|---|
Synt:em SA
 Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Chief Executive Officer | 1994-12-31 |
Former positions of Michel Kaczorek
| Companies | Position | End |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Researches and manufactures drugs for the treatment of pain and cancer | Health Technology |
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases | Health Technology |
- Stock Market
- Insiders
- Michel Kaczorek
